List of Tables
Table 1. Global Oral Meloxicam Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Meloxicam Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Oral Meloxicam Market Competitive Situation by Manufacturers in 2025
Table 4. Global Oral Meloxicam Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Oral Meloxicam Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Oral Meloxicam Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Oral Meloxicam Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Oral Meloxicam Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Oral Meloxicam, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Oral Meloxicam, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Oral Meloxicam, Product Types and Applications
Table 12. Global Key Manufacturers of Oral Meloxicam, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Meloxicam Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Meloxicam Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Meloxicam Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Oral Meloxicam Sales by Region (K Units), 2021–2026
Table 18. Global Oral Meloxicam Sales Market Share by Region (2021–2026)
Table 19. Global Oral Meloxicam Sales by Region (K Units), 2027–2032
Table 20. Global Oral Meloxicam Sales Market Share by Region (2027–2032)
Table 21. Global Oral Meloxicam Revenue by Region (US$ Million), 2021–2026
Table 22. Global Oral Meloxicam Revenue Market Share by Region (2021–2026)
Table 23. Global Oral Meloxicam Revenue by Region (US$ Million), 2027–2032
Table 24. Global Oral Meloxicam Revenue Market Share by Region (2027–2032)
Table 25. North America Oral Meloxicam Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Oral Meloxicam Sales by Country (K Units), 2021–2026
Table 27. North America Oral Meloxicam Sales by Country (K Units), 2027–2032
Table 28. North America Oral Meloxicam Revenue by Country (US$ Million), 2021–2026
Table 29. North America Oral Meloxicam Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Oral Meloxicam Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Oral Meloxicam Sales by Country (K Units), 2021–2026
Table 32. Europe Oral Meloxicam Sales by Country (K Units), 2027–2032
Table 33. Europe Oral Meloxicam Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Oral Meloxicam Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Oral Meloxicam Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Oral Meloxicam Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Oral Meloxicam Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Oral Meloxicam Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Oral Meloxicam Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Oral Meloxicam Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Oral Meloxicam Sales by Country (K Units), 2021–2026
Table 42. Latin America Oral Meloxicam Sales by Country (K Units), 2027–2032
Table 43. Latin America Oral Meloxicam Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Oral Meloxicam Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Oral Meloxicam Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Oral Meloxicam Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Oral Meloxicam Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Oral Meloxicam Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Oral Meloxicam Revenue by Country (US$ Million), 2027–2032
Table 50. Global Oral Meloxicam Sales (K Units) by Type (2021–2026)
Table 51. Global Oral Meloxicam Sales (K Units) by Type (2027–2032)
Table 52. Global Oral Meloxicam Sales Market Share by Type (2021–2026)
Table 53. Global Oral Meloxicam Sales Market Share by Type (2027–2032)
Table 54. Global Oral Meloxicam Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Oral Meloxicam Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Oral Meloxicam Revenue Market Share by Type (2021–2026)
Table 57. Global Oral Meloxicam Revenue Market Share by Type (2027–2032)
Table 58. Global Oral Meloxicam Price (US$/Unit) by Type (2021–2026)
Table 59. Global Oral Meloxicam Price (US$/Unit) by Type (2027–2032)
Table 60. Global Oral Meloxicam Sales (K Units) by Application (2021–2026)
Table 61. Global Oral Meloxicam Sales (K Units) by Application (2027–2032)
Table 62. Global Oral Meloxicam Sales Market Share by Application (2021–2026)
Table 63. Global Oral Meloxicam Sales Market Share by Application (2027–2032)
Table 64. Global Oral Meloxicam Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Oral Meloxicam Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Oral Meloxicam Revenue Market Share by Application (2021–2026)
Table 67. Global Oral Meloxicam Revenue Market Share by Application (2027–2032)
Table 68. Global Oral Meloxicam Price (US$/Unit) by Application (2021–2026)
Table 69. Global Oral Meloxicam Price (US$/Unit) by Application (2027–2032)
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Boehringer Ingelheim Oral Meloxicam Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Mylan Company Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Mylan Oral Meloxicam Product
Table 79. Mylan Recent Developments/Updates
Table 80. Teva Pharmaceutical Company Information
Table 81. Teva Pharmaceutical Description and Business Overview
Table 82. Teva Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Teva Pharmaceutical Oral Meloxicam Product
Table 84. Teva Pharmaceutical Recent Developments/Updates
Table 85. Lupin Company Information
Table 86. Lupin Description and Business Overview
Table 87. Lupin Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Lupin Oral Meloxicam Product
Table 89. Lupin Recent Developments/Updates
Table 90. Apotex Company Information
Table 91. Apotex Description and Business Overview
Table 92. Apotex Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Apotex Oral Meloxicam Product
Table 94. Apotex Recent Developments/Updates
Table 95. Dr. Reddy's Laboratories Company Information
Table 96. Dr. Reddy's Laboratories Description and Business Overview
Table 97. Dr. Reddy's Laboratories Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Dr. Reddy's Laboratories Oral Meloxicam Product
Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
Table 100. Glenmark Pharmaceuticals Company Information
Table 101. Glenmark Pharmaceuticals Description and Business Overview
Table 102. Glenmark Pharmaceuticals Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Glenmark Pharmaceuticals Oral Meloxicam Product
Table 104. Glenmark Pharmaceuticals Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Qilu Pharmaceutical Oral Meloxicam Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. Yangtze River Pharmaceutical Company Information
Table 111. Yangtze River Pharmaceutical Description and Business Overview
Table 112. Yangtze River Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Yangtze River Pharmaceutical Oral Meloxicam Product
Table 114. Yangtze River Pharmaceutical Recent Developments/Updates
Table 115. Zhejiang Xianju Pharmaceutical Company Information
Table 116. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 117. Zhejiang Xianju Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Zhejiang Xianju Pharmaceutical Oral Meloxicam Product
Table 119. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 120. Youcare Pharmaceutical Company Information
Table 121. Youcare Pharmaceutical Description and Business Overview
Table 122. Youcare Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Youcare Pharmaceutical Oral Meloxicam Product
Table 124. Youcare Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Oral Meloxicam Distributors List
Table 128. Oral Meloxicam Customers List
Table 129. Oral Meloxicam Market Trends
Table 130. Oral Meloxicam Market Drivers
Table 131. Oral Meloxicam Market Challenges
Table 132. Oral Meloxicam Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Meloxicam
Figure 2. Global Oral Meloxicam Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Meloxicam Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Oral Meloxicam Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Oral Meloxicam Market Share by Application: 2025 & 2032
Figure 8. Rheumatoid Arthritis
Figure 9. Osteoarthritis
Figure 10. Global Oral Meloxicam Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Oral Meloxicam Market Size (US$ Million), 2021–2032
Figure 12. Global Oral Meloxicam Sales (K Units), 2021–2032
Figure 13. Global Oral Meloxicam Average Price (US$/Unit), 2021–2032
Figure 14. Oral Meloxicam Report Years Considered
Figure 15. Oral Meloxicam Sales Share by Manufacturers in 2025
Figure 16. Global Oral Meloxicam Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Oral Meloxicam Players: Market Share by Revenue in Oral Meloxicam in 2025
Figure 18. Oral Meloxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Oral Meloxicam Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Oral Meloxicam Sales Market Share by Country (2021–2032)
Figure 21. North America Oral Meloxicam Revenue Market Share by Country (2021–2032)
Figure 22. United States Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Oral Meloxicam Sales Market Share by Country (2021–2032)
Figure 25. Europe Oral Meloxicam Revenue Market Share by Country (2021–2032)
Figure 26. Germany Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Oral Meloxicam Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Oral Meloxicam Revenue Market Share by Region (2021–2032)
Figure 33. China Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Oral Meloxicam Sales Market Share by Country (2021–2032)
Figure 41. Latin America Oral Meloxicam Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Oral Meloxicam Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Oral Meloxicam Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Oral Meloxicam Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Oral Meloxicam by Type (2021–2032)
Figure 52. Global Revenue Market Share of Oral Meloxicam by Type (2021–2032)
Figure 53. Global Oral Meloxicam Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Oral Meloxicam by Application (2021–2032)
Figure 55. Global Revenue Market Share of Oral Meloxicam by Application (2021–2032)
Figure 56. Global Oral Meloxicam Price (US$/Unit) by Application (2021–2032)
Figure 57. Oral Meloxicam Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
